Parian Global Management LP Renalytix PLC Transaction History

Parian Global Management LP

$30.8 Million
Q3 2022

A detailed history of Parian Global Management LP transactions in Renalytix PLC stock. As of the latest transaction made, Parian Global Management LP holds 184,799 shares of RNLX stock, worth $27,719. This represents 0.77% of its overall portfolio holdings.

Number of Shares

184,799

Previous 395,882 53.32%

Holding current value

$27,719

Previous $970,000 75.57%

% of portfolio

0.77%

Previous 4.44%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.19 - $2.78 $251,188 - $586,810	-211,083 Reduced 53.32%	184,799 $237,000
Q2 2022 Aug 15, 2022	SELL	$2.45 - $7.81 $155,768 - $496,551	-63,579 Reduced 13.84%	395,882 $970,000
Q1 2022 May 16, 2022	SELL	$5.88 - $15.9 $677,640 - $1.83 Million	-115,245 Reduced 20.05%	459,461 $3.18 Million
Q4 2021 Feb 14, 2022	BUY	$13.43 - $27.4 $649,877 - $1.33 Million	48,390 Added 9.19%	574,706 $9.14 Million
Q3 2021 Nov 15, 2021	BUY	$17.91 - $34.78 $223,875 - $434,750	12,500 Added 2.43%	526,316 $10.6 Million
Q2 2021 Aug 16, 2021	SELL	$23.56 - $34.25 $7.53 Million - $10.9 Million	-319,673 Reduced 38.35%	513,816 $15.9 Million
Q1 2021 May 17, 2021	SELL	$15.25 - $31.13 $3.69 Million - $7.54 Million	-242,195 Reduced 22.52%	833,489 $21.4 Million
Q4 2020 Feb 16, 2021	BUY	$10.69 - $16.0 $2.36 Million - $3.53 Million	220,503 Added 25.78%	1,075,684 $17.2 Million
Q3 2020 Nov 16, 2020	BUY	$10.18 - $17.3 $8.71 Million - $14.8 Million	855,181 New	855,181 $10.4 Million

Others Institutions Holding RNLX

# of Institutions

Shares Held

3.91M

Call Options Held

13.7K

Put Options Held

View Full List

About Renalytix plc

Ticker RNLX
Exchange OTC
Sector Healthcare
Industry Health Information Services
Shares Outstandng 37,445,900
Market Cap $5.62M
Description
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...

More about RNLX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parian Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Parian Global Management LP with notifications on news.

Account

Parian Global Management LP Renalytix PLC Transaction History